Le Lézard
Classified in: Business
Subject: DIV

Washington Trust Bancorp, Inc. Announces Quarterly Dividend


WESTERLY, R.I., Dec. 22, 2023 /PRNewswire/ -- The Board of Directors of Washington Trust Bancorp, Inc., (NASDAQ: WASH), yesterday declared a quarterly dividend of 56 cents per share for the quarter ending December 31, 2023. The dividend will be paid January 12, 2024 to shareholders of record on January 2, 2024.

ABOUT WASHINGTON TRUST BANCORP, INC.
Washington Trust Bancorp, Inc. ("the Corporation), NASDAQ: WASH, is the publicly-owned holding company of The Washington Trust Company ("Washington Trust", "the Bank"), with $7.2 billion in assets as of September 30, 2023.  Founded in 1800, Washington Trust is recognized as the oldest community bank in the nation, the largest state-chartered bank headquartered in Rhode Island and one of the Northeast's premier financial services companies. Washington Trust values its role as a community bank and is committed to helping the people, businesses, and organizations of New England improve their financial lives. The Bank offers a wide range of commercial banking, mortgage banking, personal banking and wealth management services through its offices in Rhode Island, Connecticut and Massachusetts and a full suite of convenient digital tools. Washington Trust is a member of the FDIC and an equal housing lender. For more information, visit the Corporation's website at ir.washtrust.com, or the Bank's website at www.washtrust.com.

SOURCE Washington Trust Bancorp, Inc.


These press releases may also interest you

at 13:39
As the originators of Direct Sourcing, TalentNet is continuing to break boundaries in the talent acquisition industry by offering a 7-day free virtual interactive experience that highlights its AI-powered TalentNavigator platform. This tool, which...

at 12:10
In line with their commitment to upholding the highest standards of transparency, below is the Adani Portfolio's Credit and Result compendium for financial year 2023-24. The performance in FY24 and the past five years signify the strength and...

at 11:00
Linker Vision, a pioneer in AI technology, is proud to announce a collaboration with NVIDIA aimed at accelerating vision AI adoption across enterprise applications with large vision models (LVMs). Through this collaboration, Linker Vision is poised...

at 10:45
ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform....

at 08:30
Vention, the company behind the cloud-based Manufacturing Automation Platform (MAP), today announced a collaboration with NVIDIA to bring industrial automation technology to small and medium manufacturers by using NVIDIA AI and accelerated computing...

1 jun 2024
Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib (JAB-21822) in combination with a SHP2 inhibitor (JAB-3312) in frontline non-small cell lung...



News published on and distributed by: